TY - JOUR
T1 - Management of cancer of the prostate
AU - Catalona, William J.
PY - 1994/10/13
Y1 - 1994/10/13
N2 - Prostate cancer is the second leading cause of death from cancer among men; 25 percent of men with prostate cancer die of the disease1. Moreover, many patients who do not die of prostate cancer require treatment to ameliorate symptoms such as pain, bleeding, and urinary obstruction. Thus, prostate cancer is also a major cause of suffering and of health care expenditures. The high rate of mortality from prostate cancer may be due to late detection. In recent studies, screening for prostate cancer has combined the measurement of serum prostate-specific antigen (PSA).
AB - Prostate cancer is the second leading cause of death from cancer among men; 25 percent of men with prostate cancer die of the disease1. Moreover, many patients who do not die of prostate cancer require treatment to ameliorate symptoms such as pain, bleeding, and urinary obstruction. Thus, prostate cancer is also a major cause of suffering and of health care expenditures. The high rate of mortality from prostate cancer may be due to late detection. In recent studies, screening for prostate cancer has combined the measurement of serum prostate-specific antigen (PSA).
UR - http://www.scopus.com/inward/record.url?scp=0028086057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028086057&partnerID=8YFLogxK
U2 - 10.1056/NEJM199410133311507
DO - 10.1056/NEJM199410133311507
M3 - Review article
C2 - 7880240
AN - SCOPUS:0028086057
SN - 0028-4793
VL - 331
SP - 996
EP - 1004
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 15
ER -
